Announcement on the Subsidiary Becoming the Marketing Authorization Holder of Amisulpride Orally Disintegrating Tablets

About this update from Shanghai Pharmaceuticals Holding Co. Ltd. Class A

Announcement on the Subsidiary Becoming the Marketing Authorization Holder of Amisulpride Orally Disintegrating TabletsThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Pharmaceuticals Holding Co. Ltd. Class A